Christina M. Ackermann

2016

In 2016, Christina M. Ackermann earned a total compensation of $4.8M as Executive Vice President and General Counsel at Valeant Pharmaceuticals International.

Compensation breakdown

Bonus$1,800,000
Option Awards$599,987
Salary$230,769
Stock Awards$2,109,143
Other$13,306
Total$4,753,204

Ackermann received $2.1M in stock awards, accounting for 44% of the total pay in 2016.

Ackermann also received $1.8M in bonus, $600K in option awards, $230.8K in salary and $13.3K in other compensation.

Rankings

In 2016, Christina M. Ackermann's compensation ranked 1,743rd out of 14,075 executives tracked by ExecPay. In other words, Ackermann earned more than 87.6% of executives.

ClassificationRankingPercentile
All
1,743
out of 14,075
88th
Division
Manufacturing
595
out of 5,489
89th
Major group
Chemicals And Allied Products
166
out of 1,895
91st
Industry group
Drugs
115
out of 1,538
93rd
Industry
Pharmaceutical Preparations
91
out of 1,176
92nd
Source: SEC filing on March 21, 2018.

Ackermann's colleagues

We found two more compensation records of executives who worked with Christina M. Ackermann at Valeant Pharmaceuticals International in 2016.

2016

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

2016

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

News

You may also like